Trump Proposes “Recalibration” of FDA Budget with $854 Million in Cuts

Drug Industry Daily
President Trump’s budget for fiscal 2018 proposes a “recalibration” of how the FDA funds its core mission of ensuring the safety of drugs, which would cut its federal spending by $854 million, to be replaced with $866 million in industry user fees.

To View This Article:


Subscribe To Drug Industry Daily